Puffy hand syndrome due to drug addiction: A case-control study of the pathogenesis

Addiction

Volumn 101, Issue 9, 2006, Pages 1347-1351

  Andresz, Valérie ^a   Marcantoni, Nicolas ^a   Binder, Florence ^b   Velten, Michel ^b   Alt, Martine ^b   Weber, Jean Christophe ^a   Stephan, Dominique ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Buprenorphine; Intravenous drug use; Puffy hand syndrome

Indexed keywords

BUPRENORPHINE; COCAINE; DIAMORPHINE; ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG MISUSE; FEMALE; FRANCE; HAND EDEMA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INJECTION SITE; INTRAVENOUS DRUG ABUSE; LYMPH FLOW; LYMPHEDEMA; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PUFFY HAND SYNDROME; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; SOCIAL ASPECT; TOURNIQUET;

BUPRENORPHINE; CASE-CONTROL STUDIES; FEMALE; FRANCE; HAND; HUMANS; LYMPHEDEMA; MALE; NARCOTIC ANTAGONISTS; RISK FACTORS; STATISTICS, NONPARAMETRIC; SUBSTANCE ABUSE, INTRAVENOUS; SYNDROME;

EID: 33746877528     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01521.x     Document Type: Article

References (20)

1. Abeles H. Puffy-hand sign of drug addiction. N Engl J Med 1965; 273:1167.
2. McCabe W. P., Ditmars D. M. Soft tissue changes in the hands of drug addicts. Plast Reconstr Surg 1973; 52:538-40.
3. Drinker C. K., Field M. E., Homans J. The experimental production of edema and elephantiasis as a result of lymphatic obstruction. Am J Physiol 1934; 108:509-20.
4. Auriacombe M., Fatseas M., Dubernet J., Daulouede J. P., Tignol J. French field experience with buprenorphine. Am J Addict 2004; 13:S17-28.
5. Carrieri M. P., Rey D., Loundou A., Lepeu G., Sobel A., Obadia Y. Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug Alcohol Depend 2003; 72:13-21.
6. Auriacombe M., Franques P., Tignol J. Deaths attributable to methadone vs buprenorphine in France. JAMA 2001; 285:45.
7. Kintz P. Deaths involving buprenorphine. a compendium of French cases. Forensic Sci Int 2001; 121:65-9.
8. Obadia Y., Perrin V., Feroni I., Vlahov D., Moatti J. P. Injecting misuse of buprenorphine among French drug users. Addiction 2001; 96:267-72.
9. Vidal-Trecan G., Varescon I., Nabet N., Boissonnas A. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug Alcohol Depend 2003; 69:175-81.
10. Rowe, R. C., Sheskey, P. J., Weller, P. J., editors. Handbook of pharmaceutical excipients, 4th edn. London: Pharmaceutical Press; 2003.
11. Simonnet N., Marcantoni N., Simonnet L., Griffon C., Chakfe N., Wertheimer J. et al. Volumineux oedèmes des mains chez des patients toxicomanes intraveineux au long cours [Puffy hand in long-term intravenous drug users]. J Mal Vasc 2004; 29:201-4.
12. Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol 2004; 150:1-10.
13. Neviaser R. J., Butterfield W. C., Wieche D. R. The puffy hand of drug addiction, a study of pathogenesis. J Bone Joint Surg Am 1972; 54:629-33.
14. Valenciano M., Emmanuelli J., Lert F. Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction 2001; 96:597-606.
15. Brownse N. L. The diagnosis and management of primary lymphedema. J Vasc Surg 1986; 3:181-4.
16. Darke S., Ross J., Kaye S. Physical injecting sites among injecting drug users in Sydney, Autralia. Drug Alcohol Depend 2001; 62:77-82.
17. De Godoy J. M., De Godoy M. F., Valente A., Camacho E. L., Paiva E. V. Lymphoscintigraphic evaluation in patients after erysipelas. Lymphology 2000; 33:177-80.
18. Guichard A., Lert F., Calderon C., Gaigi H., Maget O., Soletti J. et al. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction 2003; 98:1585-97.
19. Sullivan L. E., Metzger D. S., Fudala P. J., Fiellin D. A. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 2004; 100:150-8.
20. Hallinan R., Byrne A., Amin J., Dore G. J. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. J Gastroenterol Hepatol 2005; 20:1082-6.